ENO1 and pancreatic neoplasm: ENO1 has been found to induce autoantibody production in patients with cholangiocarcinoma, breast tumor, head and neck tumor, leukemia, lung tumor, pancreatic tumor, and melanoma (26, 28, 50–52).